Status:

COMPLETED

An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence

Lead Sponsor:

Wei Hao

Conditions:

Methamphetamine Dependence

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. paliperidone are Second generation antipsychotics,and have effects of bloc...

Detailed Description

Methods:A Multiple-Center, Randomized, Double-Blind.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Men and women aged 18 years to 60 years
  • Met the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) criteria for METH dependence with psychosis
  • Completing inpatient METH detoxification (≤30 days) with psychotic symptoms disappeared
  • Beoff any anti-psychotic medication for 7 days after discharging from hospital were enrolled at clinical site
  • Participants were interesting in reducing or stopping METH use
  • Every patient also had a significant other (eg., spouse or relative) who supervised their compliance with the visit schedule and study procedures
  • Women of childbearing potential agreed to use contraception during the study.
  • Exclusion criteria:
  • Pregnancy or breastfeeding;
  • Significant medical conditions (eg., acute renal failure, endocarditis, and tuberculosis); hepatic failure; past or present history of an AIDS-indicator disease; active hepatitis or aspartate amino transferase or alanine aminotransferase more than three times the upper limit of normal
  • Known intolerance or hypersensitivity to paliperidone ER; other psychosis; present dependence on substances other than METH or poly-substance abuse.

Exclusion

    Key Trial Info

    Start Date :

    February 1 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2014

    Estimated Enrollment :

    80 Patients enrolled

    Trial Details

    Trial ID

    NCT01825928

    Start Date

    February 1 2013

    End Date

    July 1 2014

    Last Update

    July 13 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Second Xiangya Hospital of Central University

    Changsha, Hunan, China, 410011